We have just awarded funding to Margot Mayer-Proschel, PhD at the University of Rochester to characterize a new mouse model that her lab has developed for A-T. Previous A-T mouse models have been useful for studying the biochemical, cancer, and immunological problems associated with A-T but haven’t had the brain degeneration and loss of muscle control seen in humans with the disease. And so, for the first time in history, Dr. Mayer-Proschel’s mice may allow researchers to overcome a huge barrier that has hampered A-T researchers from testing new therapies for the devastating neurological problems of A-T.
